SKF7™ Study in Indonesia is the First Anti-Obesity Malaysian-led Clinical Trial Registered on

Written by Medika Natura

Formerly known as Orchid Life, Medika Natura is a pioneer in the end-to-end development, production and commercializing of botanical bio-active compounds native to Southeast Asia.

22 March 2021

Phase 2 clinical studies of SKF7™ conducted in Indonesia is the first Malaysian-led anti-obesity study to be registered on, the world’s largest clinical trial database.

Medika Natura has initiated Phase 2 in-human clinical trials on its proprietary ingredient – SKF7™ – in clinics and general hospitals across Indonesia. A first for Malaysia, these clinical trials are the first Malaysian-led anti-obesity studies to be officially registered on the website. These randomized double-blind placebo-controlled studies are also the first study of its kind to be conducted in Indonesia, aimed at determining the efficacy of SKF7™ in curtailing obesity, to enable it to be classified and marketed as an anti-obesity botanical drug. is run by the United States National Library of Medicine and hosts over 350,000 trials from over 200 countries.

Other News & Updates